Revenue falls 33% over the half year for the ailing Australian pharmaceutical as it pivots from generics to the branded market

Plummeting sales and profit following government price regulations pushes Chemiphar to target international expansion

Teva has agreed to settle Florida’s price-fixing allegations for $6.73m, its fifth and largest state settlement sum so far. Payouts to further states are expected.

The US FDA has accepted a BLA for Henlius’ trastuzumab biosimilar candidate HLX02, marking another step in the Chinese company’s push for the US oncology market

Torrent’s quarterly revenues were up by 18% to INR24.9bn in Q3 FY2023. Branded generics and the Brazilian market did much of the heavy lifting.

Ypsomed AG will manufacture insulin dosing injector pens for non-profit Civica. Civica has also paired up with AmerisourceBergen for generics supply chain support across the US.